These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 18953547)
1. Botulinum toxin in paediatric urology: a systematic literature review. DasGupta R; Murphy FL Pediatr Surg Int; 2009 Jan; 25(1):19-23. PubMed ID: 18953547 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Leippold T; Reitz A; Schurch B Eur Urol; 2003 Aug; 44(2):165-74. PubMed ID: 12875934 [TBL] [Abstract][Full Text] [Related]
3. Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin. Gallien P; Robineau S; Verin M; Le Bot MP; Nicolas B; Brissot R Arch Phys Med Rehabil; 1998 Jun; 79(6):715-7. PubMed ID: 9630155 [TBL] [Abstract][Full Text] [Related]
4. Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction. Smith CP; Somogyi GT; Chancellor MB Curr Urol Rep; 2002 Oct; 3(5):382-7. PubMed ID: 12354347 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity. Casanova N; McGuire E; Fenner DE Int J Gynaecol Obstet; 2006 Dec; 95(3):305-11. PubMed ID: 17070528 [TBL] [Abstract][Full Text] [Related]
16. Onabotulinum toxin A: a therapeutic option for refractory neurogenic detrusor overactivity and idiopathic overactive bladder. Ellsworth P; Travis M Urol Nurs; 2014; 34(4):165-71. PubMed ID: 25233617 [TBL] [Abstract][Full Text] [Related]